Biomarkers support the etiological diagnosis of neurocognitive disorders in vivo. Incomplete evidence is available to drive clinical decisions; available diagnostic algorithms are generic and poorly helpful in clinical practice. We aim to develop a biomarker-based diagnostic algorithm for MCI patients, leveraging on knowledge from recognized national experts.
|Titolo:||Italian consensus recommendations for the biomarker-based etiological diagnosis in MCI patients|
|Data di pubblicazione:||2020|
|Appare nelle tipologie:||01.01 Articolo in Rivista|